High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorIndonesia University
About this trial
High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery
Eligibility criteria
Qualifiers
Patients under 18 years of age.
Post-cardiac surgery patients in the CICU of Cipto Mangunkusumo National General Hospital
Patients at high risk of extubation failure (e.g., young age, open sternotomy, mechanical ventilation >48 hours).
Patients who pass the extubation readiness test and spontaneous breathing trial.
Disqualifiers
Diaphragmatic paralysis.
Decreased consciousness.
Neuromuscular disease.
Pneumothorax without drainage.
Trial design
Treatments tested in this trial
- High Flow Nasal Cannula (HFNC)
- Non-Invasive Ventilation (NIV)
Treatment groups
114 Participants
are divided into 2 treatment groupsLocations
1Faculty of Medicine, University of Indonesia10430, JakartaDKI Jakarta, Indonesia
Sponsors and collaborators
Indonesia University
Lead sponsor
Source ClinicalTrials.gov